Astera Labs, Inc. $ALAB is Renaissance Capital LLC’s 3rd Largest Position

Renaissance Capital LLC cut its stake in Astera Labs, Inc. (NASDAQ:ALAB) by 35.9% in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 81,126 shares of the company’s stock after selling 45,497 shares during the period. Astera Labs accounts for about 8.9% of Renaissance Capital LLC’s portfolio, making the stock its 3rd largest position. Renaissance Capital LLC’s holdings in Astera Labs were worth $15,884,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other hedge funds have also bought and sold shares of the stock. Oliver Lagore Vanvalin Investment Group purchased a new position in shares of Astera Labs in the second quarter worth $29,000. Grove Bank & Trust acquired a new position in shares of Astera Labs in the 3rd quarter valued at $68,000. Bernard Wealth Management Corp. purchased a new position in Astera Labs in the 2nd quarter worth $36,000. Clearstead Trust LLC lifted its position in Astera Labs by 46,100.0% during the 2nd quarter. Clearstead Trust LLC now owns 462 shares of the company’s stock worth $42,000 after acquiring an additional 461 shares during the period. Finally, Advisors Asset Management Inc. lifted its position in Astera Labs by 68.6% during the 2nd quarter. Advisors Asset Management Inc. now owns 477 shares of the company’s stock worth $43,000 after acquiring an additional 194 shares during the period. Institutional investors and hedge funds own 60.47% of the company’s stock.

Astera Labs Price Performance

NASDAQ:ALAB opened at $170.84 on Wednesday. The company has a 50 day moving average price of $160.32 and a 200-day moving average price of $159.75. Astera Labs, Inc. has a 1-year low of $47.13 and a 1-year high of $262.90. The firm has a market cap of $28.85 billion, a price-to-earnings ratio of 153.91, a price-to-earnings-growth ratio of 3.17 and a beta of 1.51.

Astera Labs (NASDAQ:ALAB) last released its quarterly earnings results on Tuesday, November 4th. The company reported $0.49 EPS for the quarter, beating the consensus estimate of $0.39 by $0.10. Astera Labs had a net margin of 27.50% and a return on equity of 13.48%. The company had revenue of $230.58 million for the quarter, compared to analyst estimates of $206.42 million. During the same quarter last year, the business earned $0.23 earnings per share. The firm’s revenue was up 103.9% on a year-over-year basis. Astera Labs has set its Q4 2025 guidance at 0.50-0.510 EPS. On average, sell-side analysts anticipate that Astera Labs, Inc. will post 0.34 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

A number of research analysts have recently weighed in on ALAB shares. Wall Street Zen lowered Astera Labs from a “buy” rating to a “hold” rating in a report on Tuesday, November 11th. Bank of America assumed coverage on shares of Astera Labs in a research report on Friday, October 3rd. They set a “neutral” rating and a $230.00 price target for the company. Cowen restated a “hold” rating on shares of Astera Labs in a research note on Wednesday, November 5th. Raymond James Financial initiated coverage on shares of Astera Labs in a research note on Friday, November 21st. They issued a “hold” rating on the stock. Finally, BNP Paribas began coverage on shares of Astera Labs in a report on Thursday, November 20th. They issued an “outperform” rating on the stock. One investment analyst has rated the stock with a Strong Buy rating, fifteen have given a Buy rating and eight have given a Hold rating to the company. Based on data from MarketBeat, Astera Labs has a consensus rating of “Moderate Buy” and an average target price of $188.17.

Insider Transactions at Astera Labs

In other news, CFO Michael Truett Tate sold 11,430 shares of the business’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $1,653,806.70. Following the completion of the sale, the chief financial officer directly owned 192,297 shares in the company, valued at $27,823,452.93. The trade was a 5.61% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CEO Jitendra Mohan sold 90,459 shares of the company’s stock in a transaction that occurred on Monday, November 17th. The stock was sold at an average price of $144.69, for a total value of $13,088,512.71. Following the transaction, the chief executive officer directly owned 2,080,418 shares of the company’s stock, valued at approximately $301,015,680.42. The trade was a 4.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 576,936 shares of company stock worth $87,409,540 over the last quarter. Company insiders own 12.50% of the company’s stock.

About Astera Labs

Astera Labs is a fabless semiconductor company that develops connectivity solutions for data center and cloud infrastructure. The firm focuses on addressing signal integrity and link management challenges that arise as server architectures incorporate higher-bandwidth processors and accelerators. Its technology is aimed at improving reliability and performance for high-speed interconnects used in servers, storage systems and compute accelerators.

The company’s product portfolio centers on silicon devices and accompanying firmware and software that enhance and manage high-speed links.